
Mouse CD40L PicoKine ELISA Kit standard curve
Mouse CD40 Ligand/TNFSF5/CD40LG ELISA Kit PicoKine(r)
EK0574
Product group Assays
Overview
- SupplierBoster Bio
- Product NameMouse CD40L PicoKine ELISA Kit
- Delivery Days Customer9
- ApplicationsELISA
- Applications SupplierELI
- Assay Detection Range62.5 pg/ml - 4,000 pg/ml
- Assay Sensitivity<10 pg/ml
- Assay Time15-20
- CertificationResearch Use Only
- Scientific DescriptionMouse CD40 Ligand/TNFSF5/CD40LG ELISA Kit PicoKine® (96 Tests). Quantitate Mouse Cd40lg in cell culture supernatants, cell lysates, serum and plasma (heparin, EDTA). Sensitivity: 10pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
- Reactivity SupplierMouse CD40L
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116158
References
- Ying M, Zheng B, Yu Q, et al. Ganoderma atrum polysaccharide ameliorates intestinal mucosal dysfunction associated with autophagy in immunosuppressed mice. Food Chem Toxicol. 2020,138:111244. doi: 10.1016/j.fct.2020.111244Read this paper
- Zhan T, Wei T, Dong L, et al. Cangrelor alleviates bleomycin-induced pulmonary fibrosis by inhibiting platelet activation in mice. Mol Immunol. 2020,120:83-92. doi: 10.1016/j.molimm.2020.01.017Read this paper
- Zhu M, Liu H, Sun K, et al. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss. Biomed Pharmacother. 2020,123:109769. doi: 10.1016/j.biopha.2019.109769Read this paper
- Ansari H, Tahmasebi-Birgani M, Bijanzadeh M, et al. Study of the immunogenicity of outer membrane protein A (ompA) gene from Acinetobacter baumannii as DNA vaccine candidate in vivo. Iran J Basic Med Sci. 2019,22(6):669-675. doi: 10.22038/ijbms.2019.30799.7427Read this paper
- Zhao L, Cai C, Wang J, et al. Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity. Front Pharmacol. 2017,8:928. doi: 10.3389/fphar.2017.00928Read this paper
- Xu F, Dong Y, Huang X, et al. Decreased osteoclastogenesis, osteoblastogenesis and low bone mass in a mouse model of type 2 diabetes. Mol Med Rep. 2014,10(4):1935-41. doi: 10.3892/mmr.2014.2430Read this paper



